pad

Case Study 3

Surviving Against All Odds: Analysis of 6 Case Studies of Patients With Cancer Who Followed the Gerson Therapy

A. Molassiotis, RN, PhD, and P. Peat, RGN, DiplPallCare

Case 3

This case is a 59-year-old woman (born in 1947) diagnosed with lobular carcinoma of the right breast in January 1992 at the age of 45, being node negative and ER positive. The treatment plan was wide local excision followed by radiotherapy, the latter commencing on January 8, 1993.

In May 1995, a surveillance mammogram showed microcalcification in her left breast. Needle biopsy showed ductal carcinoma in situ. It was felt to be extensive, and the treatment plan was left mastectomy. Evidence of invasive lobular cancer was found (size/extent not reported).

The axilla was not operated on at that stage, no radiotherapy was given, and there was no further adjuvant chemotherapy or hormonal therapy. In December 1997, she presented with pain in the right axilla and breast changes for the past 2 to 3 months; imaging and cytology confirmed recurrent tumor within the right breast together with a palpable node within the right axilla.

The patient was being planned for a right mastectomy and level 2 axillary dissection when staging by CT scan showed evidence of asymptomatic liver metastases (up to 10), although the lungs and bones were clear. She was commenced on tamoxifen.

She started the Gerson regimen in January 1998.

Tamoxifen was discontinued in July 1999 at the patient’s own request. In December 1999, she presented with a number of fine nodules and a hard nodule in her right axilla, which led to the clinical conclusion of “clearly showing evidence of local recurrence of breast cancer.” Tamoxifen was reintroduced.

In January 2000, liver ultrasound showed no evidence of liver metastasis, and the same was shown in another liver ultrasound in September 2000. In August 2000, it was noted that the skin nodules, which had disappeared, had not recurred. Tests showed that the patient was postmenopausal, and her hormone treatment was changed to letrozole.

To date, concurrent examinations have shown no recurrence of her disease.

Integr Cancer Ther 2007; 6; 80

Remember we are NOT Doctors and have NO medical training.

This site is like an Encylopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.